Characteristics and Cluster of Lifestyle Factors in Neurological Outpatients
Abstract
Material and Methods: A total of 153 subjects were recruited from the ambulatory Unit Operative Complex of neurology, of S. Eugenio Hospital in Rome. This study was conducted from January, 2017 to May, 2019. Body Mass Index (general obesity) and Waist Circumference (abdominal obesity) were used as outcome measures. Lifestyle behaviours were assessed via questionnaires.
Results: The percentage of overweight/obesity was74.0% (77.0% in males and 70.0% in females); whereas, the percentage of subjects with abdominal obesity (67.0%) was significantly higher in females than in males (76.0% vs 60.0%, p-value= 0.038). Also, among patients suffering from neurological diseases there was a significant prevalence of: (i) males, (ii) subjects with low education levels, iii) elderly adults (aged over 75), and iv) people having a significantly lower percentage of appropriate hours of sleep. Three clusters were identified for males and four for females, according to lifestyles. The ‘unhealthy habits’ cluster, dominant among males (38.4%), was characterized by high prevalence of overweight/obese, and abdominal obese subjects; high prevalence of wine and alcoholic beverages consumers, high prevalence of inactive subjects; especially in females and high prevalence of neurological diseases among males.
Conclusion: The clusters were identified according to lifestyles, and the main, important findings showed a high prevalence of unhealthy lifestyle clustering was dominant among male, elderly people with neurological diseases.
Keywords
Full Text:
PDFReferences
Yanguas-Casás N. Sex Differences in Neurodegenerative Diseases. SM J Neurol Disord Stroke 2017;3:1014.
Batista P, Pereira A. Quality of life of patients with neurodegenerative diseases. J Neurol Neurosci 2016;7:1–7.
Awan S, Shafqat S, Kamran Kamal A, Sonawalla A, Siddiqui S, Siddiqui F, et al. Pattern of neurological diseases in adult outpatient neurology clinics in tertiary care hospital. BMC Res Notes 2017;10:545.
Lopez A.D, Mathers C, Ezzati M. Global Burden of Disease and Risk Factors. Washington: The World Bank and Oxford University Press; 2006.
Birbeck GL, Meyer AC, Ogunniyi A. Nervous system disorders across the life course in resource-limited settings. Nature 2015;527:S167-71.
Ministry of Health. Sistema di valutazione e monitoraggio della qualità dell’assistenza e delle performance dei sistemi sanitari [homepage on the Internet]. Rome: Ministry of Health; 2011 [cited 2011 Dec 13]. Aavailable from: www.rssp.salute.gov. it/rssp/paginaParagrafoRssp
World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Technical Report Series No. 854. Geneva: WHO; 1995.
Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev 2010;23: 247-69.
Mazon JN, De-Mello AH, Ferreira GK, Rezin GT. The impact of obesity on neurodegenerative diseases. Life Sci 2017; 182:22–8.
McShea S. Obesity: “can the battle be won?”. Physician Assist Clin 2017;2:87–106.
Procaccini C, Santopaolo M, Faicchia D, Colamatteo A, Formisano L, de Candia P, et al. Matarese G role of metabolism in neurodegenerative disorders. Metabolism 2016;65:1376– 90.
Davis C, Mudd J, Hawkins M. Neuroprotective effects of leptin in the context of obesity and metabolic disorders. Neurobiol Dis 2014;72:61–71.
Hofman A, Murad SD, Van Duijn CM, Franco OH, Goedegebure A, Arfan Ikram M, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol 2013; 28:889–926.
Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2197–223.
Dorszewska J, Prendecki M, Oczkowska A, Dezor M, Kozubski W. Molecular basis of familial and sporadic Alzheimer’s disease. Curr Alzheimer Res 2016;13:952-63.
Loke H, Harley V, Lee J. Biological factors underlying sex differences in neurological disorders. Int J Biochem Cell Boil 2015;65:139–50.
Young LJ, Pfaff DW. Sex differences in neurological and psychiatric disorders. Front Neuroendocrinol 2014;35:253–4.
Ngun TC, Ghahramani N, Sánchez FJ, Bocklandt S, Vilain E. The genetics of sex differences in brain and behavior. Front Neuroendocr 2011;32:227–46.
McCarthy MM, Arnold AP, Ball GF, Blaustein JD, De Vries GJ. Sex differences in the brain: the not so inconvenient truth. J Neurosci 2012;32:2241–7.
Hanamsagar R, Bilbo SD. Sex differences in neurodevelopmental and neurodegenerative disorders: focus on microglial function and neuroinflammation during development. J Steroid Biochem Mol Boil 2016;160:127–33.
Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62:847–55.
Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines. Pharmacol Rev 2010;62:155–98.
Gillies GE, Pienaar IS, Vohra S, Qamhawi Z. Sex differences in parkinson’s disease. Front Neuroendocr 2014;35:370–84.
Haaxma CA, Bloem BR, Borm GF, Oyen WJ, Leenders KL, Eshuis S, et al. Gender differences in parkinson’s disease. J Neurol Neurosurg Psychiatry 2007;78:819–24.
Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, Bloch DA, et al. Incidence of parkinson’s disease: variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015–22.
Li R, Singh M. Sex differences in cognitive impairment and Alzheimer’s disease. Front Neuroendocr 2014;35:385–403.
Hebert LE, Weuve J, Scherr PA, Evans DA. Alzheimer disease in the United States (2010–2050) estimated using the 2010 census. Neurology 2013;80:1778–83.
Caamano-Isorna F, Corral M, Montes-Martinez A, Takkouche B. Education and dementia: a meta-analytic study. Neuroepidemiology 2006;26:226-32.
Meng X, D'Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS One 2012;7. doi: 10.1371/journal.pone.0038268.
Lenehan ME, Summers MJ, Saunders NL, Summers JJ, Vickers JC. Relationship between education and age-related cognitive decline: a review of recent research. Psychogeriatrics 2014;15:154-62.
Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002;8:448-60.
Jones RN, Manly J, Glymour MM, Rentz DM, Jefferson AL, Stern Y. Conceptual and measurement challenges in research on cognitive reserve. J Int Neuropsychol Soc 2011;17:593- 601.
Benito-León J, Bermejo-Pareja F, Vega S, Louis ED. Total daily sleep duration and the risk of dementia: a prospective population-based study. Eur J Neurol 2009;16:990–7.
Oosterman JM, van Someren EJ, Vogels RL, Van Harten B, Scherder EJ. Fragmentation of the rest-activity rhythm correlates with age-related cognitive deficits. J Sleep Res 2009;18:129–35.
Benito-León J, Louis ED, Villarejo-Galende A, Romero JP, Bermejo Pareja F. Long sleep duration in elders without dementia increases risk of dementia mortality (NEDICES). Neurology 2014;83:1530–7.
Da Silva RA. Sleep disturbances and mild cognitive impairment: a review. Sleep Sci 2015;8:36–41.
Spira AP, Stone KL, Redline S, Ensrud KE, Ancoli-Israel S, Cauley JA, et al. Actigraphic sleep duration and fragmentation in older women: associations with performance across cognitive domains. Sleep 2017;40. doi: 10.1093/sleep/ zsx073.
Kimura N, Aso Y, Yabuuchi K, Ishibashi M, Hori D, Sasaki Y, et al. Modifiable lifestyle factors and cognitive function in older people: a cross-sectional observational study. Front Neurol 2019;10:1–12.
World Health Organization. Library cataloging-in-publication data: innovative care for chronic conditions: building blocks for action. Geneva: WHO; 2002.
Wang X, Gao H, Xu H. Cluster analysis of unhealthy lifestyles among elderly adults with prediabetes: a crosssectional study in rural china. Diabetes Ther 2019;10:1935– 48.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.